InSite Vision Inc. (fka INSV)

[$heff]

INSV (.37) breakthrough w/big Pharma..This is a key article w/Pfizer & Bausch & Lomb. It was a writeup in the Ocular Surgery News. It speaks to the fact that Pfizer is a key player in the opthalmology space and particularly with Bausch & Lomb. So much so that they are going to be expanding their sales force and putting big money into this opthalmology.
http://www.box.net/shared/emlql6jtxo

"The other major move by Pfizer, announced in March, is a plan to co-promote eye care products with Bausch & Lomb. The 5-year plan essentially doubles the sales force of the two companies while expanding their potential offerings."

Best, Sheff